Literature DB >> 12411419

Possible role of histamine (H1- and H2-) receptors in the regulation of meningeal blood flow.

Mária Dux1, Nina Schwenger, Karl Messlinger.   

Abstract

1. Vasodilatation in the dura mater has been suggested to play an important role in the pathophysiology of vascular headaches. Histamine may contribute to these vascular changes. The aim of the present study was to examine the role of different histamine receptors in histamine-induced meningeal hyperperfusion using laser Doppler flowmetry. 2. The blood flow in the medial meningeal artery was monitored in the exposed parietal dura mater encephali of barbiturate anaesthetized rats. Local application of histamine (10(-5) and 10(-4) M) onto the dura caused increases in flow to 114.2+/-9.6 and 135.1+/-19.1%, respectively, of the basal flow. 3. Flow increases induced by topical application of histamine (10(-4) M) were reduced by local pretreatment with the H(2)-receptor antagonist cimetidine (0.4 and 4 mM) to 63.4+/-17 and 37.8+/-18.8%, respectively. Systemic pre-administration of cimetidine (5 mg kg(-1) i.v.) did not change histamine-induced flow increases. 4. Local pretreatment with the H(1)-receptor antagonist cetirizine (2 micro M) further increased the flow evoked by topical histamine administration (10(-4) M) to 123.5+/-14.7% of the histamine control. 5. Increases in blood flow induced by i.v. administration of histamine (10 micro g kg(-1)) were reduced by i.v. pre-injection of cetirizine (50 micro g kg(-1)) to 31.9+/-9% but not by i.v. cimetidine (5 mg kg(-1)). 6. We conclude that histamine-induced relaxation of dural arterial vessels is mediated by H(2)-receptors, most likely located on vascular smooth muscle cells, and by endothelial H(1)-receptors. In addition, H(1)-receptors on smooth muscle cells may mediate vasoconstriction.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12411419      PMCID: PMC1573566          DOI: 10.1038/sj.bjp.0704946

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  29 in total

1.  Nitric oxide synthase inhibition in the histamine headache model.

Authors:  L Schmetterer; M Wolzt; U Graselli; O Findl; K Strenn; S Simak; J Kastner; H G Eichler; E A Singer
Journal:  Cephalalgia       Date:  1997-05       Impact factor: 6.292

2.  Increased plasma histamine levels in migraine patients.

Authors:  R V Heatley; J A Denburg; N Bayer; J Bienenstock
Journal:  Clin Allergy       Date:  1982-03

3.  Responses of feline trigeminal spinal tract nucleus neurons to stimulation of the middle meningeal artery and sagittal sinus.

Authors:  K D Davis; J O Dostrovsky
Journal:  J Neurophysiol       Date:  1988-02       Impact factor: 2.714

4.  Release of substance P, calcitonin gene-related peptide and prostaglandin E2 from rat dura mater encephali following electrical and chemical stimulation in vitro.

Authors:  A Ebersberger; B Averbeck; K Messlinger; P W Reeh
Journal:  Neuroscience       Date:  1999-03       Impact factor: 3.590

Review 5.  Investigations into the role of nitric oxide and the large intracranial arteries in migraine headache.

Authors:  L L Thomsen
Journal:  Cephalalgia       Date:  1997-12       Impact factor: 6.292

6.  Influence of the endothelium on histamine-induced relaxation of rat middle cerebral arteries in vitro.

Authors:  S Benedito; D Prieto; N C Nyborg
Journal:  J Cardiovasc Pharmacol       Date:  1991-01       Impact factor: 3.105

7.  A nitric oxide donor (nitroglycerin) triggers genuine migraine attacks.

Authors:  L L Thomsen; C Kruuse; H K Iversen; J Olesen
Journal:  Eur J Neurol       Date:  1994-09       Impact factor: 6.089

8.  Trigeminal sensory fiber stimulation induces morphological changes reflecting secretion in rat dura mater mast cells.

Authors:  V Dimitriadou; M G Buzzi; M A Moskowitz; T C Theoharides
Journal:  Neuroscience       Date:  1991       Impact factor: 3.590

Review 9.  Neurogenic inflammation in the pathophysiology and treatment of migraine.

Authors:  M A Moskowitz
Journal:  Neurology       Date:  1993-06       Impact factor: 9.910

10.  Cluster headache: trial of a combined histamine H1 and H2 antagonist treatment.

Authors:  D Russell
Journal:  J Neurol Neurosurg Psychiatry       Date:  1979-07       Impact factor: 10.154

View more
  6 in total

1.  Pharmacological investigations on mast cell stabilizer and histamine receptor antagonists in vincristine-induced neuropathic pain.

Authors:  Amteshwar Singh Jaggi; Gunjanpreet Kaur; Anjana Bali; Nirmal Singh
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2017-09-15       Impact factor: 3.000

2.  Meningeal blood flow is controlled by H2 S-NO crosstalk activating a HNO-TRPA1-CGRP signalling pathway.

Authors:  Mária Dux; Christine Will; Birgit Vogler; Milos R Filipovic; Karl Messlinger
Journal:  Br J Pharmacol       Date:  2015-06-12       Impact factor: 8.739

Review 3.  Migraine: where and how does the pain originate?

Authors:  Karl Messlinger
Journal:  Exp Brain Res       Date:  2009-03-14       Impact factor: 1.972

4.  Capsaicin-sensitive neurogenic sensory vasodilatation in the dura mater of the rat.

Authors:  Maria Dux; Péter Sántha; Gabor Jancsó
Journal:  J Physiol       Date:  2003-08-29       Impact factor: 5.182

5.  Morphine is an arteriolar vasodilator in man.

Authors:  Reza Afshari; Simon R J Maxwell; David J Webb; D Nicholas Bateman
Journal:  Br J Clin Pharmacol       Date:  2009-04       Impact factor: 4.335

6.  Endovanilloids are potential activators of the trigeminovascular nocisensor complex.

Authors:  Mária Dux; Éva Deák; Noémi Tassi; Péter Sántha; Gábor Jancsó
Journal:  J Headache Pain       Date:  2016-05-17       Impact factor: 7.277

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.